Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride

Riggs, Robert M; English, Brett A; Webster, Andrew A; McGuire, J Michael; Riordan, James M; Worthington, Mary A

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride

Author(s): Riggs Robert M, English Brett A, Webster Andrew A, McGuire J Michael, Riordan James M, Worthington Mary A

Issue: May/Jun 1999 - Compounding for Animals
View All Articles in Issue

Page(s): 235-238

Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride Page 1

Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride Page 2

Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride Page 3

Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride Page 4

Download in electronic PDF format for $75

Abstract: The treatment of status epilepticus may require in certain situations the concurrent administration of lorazepam or midazolam with fosphenytoin. Simulated Y-site fosphenytoin/ lorazepam and fosphenytoin/midazolam hydrochloride admixtures, respectively, in 0.9% sodium chloride injection were analyzed using a stability-indicating high-performance liquid chromatography (HPLC) method. Each drug was analyzed for stability by HPLC from three simulated Y-site samples over an eight-hour period. The HPLC assay results indicate that both fosphenytoin and lorazepam are stable together at a Y site over an eight-hour period. In addition, there was neither a change in sample clarity nor a change in pH over the same period. The results indicate that, when medically necessary, fosphenytoin and lorazepam in 0.9% sodium chloride injection can be administered via the same intravenous (IV) line. Midazolam free base was precipitated upon admixture of midazolam hydrochloride and fosphenytoin solutions. Therefore, midazolam hydrochloride and fosphenytoin should not be given via the same IV line.

Related Keywords: status epilepticus

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride Riggs Robert M, English Brett A, Webster Andrew A, McGuire J Michael, Riordan James M, Worthington Mary A	May/Jun 1999 Pg. 235-238
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei	Jan/Feb 2011 Pg. 74-77
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A	May/Jun 2005 Pg. 235-237
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A	Mar/Apr 2008 Pg. 170-173
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A	Mar/Apr 2008 Pg. 156-160
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital English Brett A, Riggs Robert M, Webster Andrew A, Benner Kimberly W	Jan/Feb 1999 Pg. 64-66
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N	Sep/Oct 2003 Pg. 389-393
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A	Nov/Dec 2007 Pg. 520-524
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A	Jul/Aug 2008 Pg. 368-371
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel	Jan/Feb 2009 Pg. 78-80
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A	May/Jun 2005 Pg. 238-241
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Inagaki Kazuhiro, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio	Jul/Aug 1998 Pg. 318-321
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Williams Kimberly Y, Baker Ma	Jan/Feb 2001 Pg. 69-73
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A	May/Jun 2008 Pg. 276-278
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration Inagaki Kazuhiro, Miyamoto Yuriko, Kurata Niroko, Nakane Shigeki, Gill Mark A, Nishida Mikio	Mar/Apr 2000 Pg. 150-153
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S	Jul/Aug 2001 Pg. 314-319
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher	Jul/Aug 2002 Pg. 311-315
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P	May/Jun 2002 Pg. 230-233
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Trissel Lawrence A, Zhang Yanping	Jul/Aug 2005 Pg. 320-322
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration Ramaley Corrine C, Li Feng, Du Chengan	Sep/Oct 2013 Pg. 436-438
Return to Top